Skip to main content

Behavioural antimicrobial stewardship interventions in outpatient settings: a systematic review and meta-analysis of physician-targeted approaches

Journal
Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases (Q1)
Published
12 September 2026
Study design
Systematic review / meta-analysis of RCTs
Evidence level
Level 1, High (CEBM 1a)
Authors
Dariga Zhazykhbayeva, Zhanar Kosherova, Zhandos Salpynov, Nabiy Arystan, Alissa Koltunova, Ulzhan Khassen, et al.
PMID
42731627
DOI
10.1016/j.cmi.2026.09.014

Why clinicians should know about it

  • Picked for Family Practice (paper of the day, 15 September 2026): Behavioural antimicrobial stewardship interventions in outpatients
  • Picked for Microbiology (medical) (paper of the day, 15 September 2026).

Abstract

BACKGROUND: Antimicrobial stewardship (AMS) interventions are increasingly implemented in outpatient settings to improve the rational use of antibiotics and mitigate antimicrobial resistance. OBJECTIVES: To assess the effect of physician-targeted behavioural AMS interventions on outpatient antibiotic use. METHODS: Data Sources: PubMed/MEDLINE, Cochrane Library, APA PsyNet, Epistemonikos (PROSPERO CRD420251110732). STUDY ELIGIBILITY CRITERIA: Randomized controlled trials (RCTs) and non-RCTs evaluating AMS interventions. PARTICIPANTS: Primary care physicians. INTERVENTIONS: AMS interventions with at least one behavioural component. Assessments of risk of bias: The revised Cochrane risk-of-bias tool and the Joanna Briggs Institute tool were used. Methods of data synthesis: We categorized AMS interventions along two dimensions, into seven broad types and by number of components (single, combined, multicomponent). Adjusted and crude estimates were calculated in random-effects meta-analyses to assess overall, recommended/first-line, and non-recommended/inappropriate antibiotic use, stratified by study design. Univariable random-effects meta-regression was conducted to explore whether intervention effects varied by AMS components. Publication bias was assessed using Egger's test, funnel plots, and sensitivity analysis. RESULTS: Eighty-five studies were included, 43(50.6%) RCTs and 42 (49.4%) non-RCTs. Among RCTs, behavioural AMS interventions reduced overall antibiotic use (0.89; 95% CI: 0.84-0.94) and non-recommended/inappropriate use (0.61; 95% CI: 0.49-0.75) and increased recommended/first-line use (1.35; 95% CI: 1.16-1.58). Corresponding estimates for non-RCTs were (0.88; 95% CI: 0.77-1.01), (0.54; 95% CI: 0.47-0.62), and 1.52 (95% CI: 1.34-1.71). In meta-regression, each additional intervention component was consistently associated with a greater reduction in non-recommended/inappropriate use (RCTs 13%; 95% CI: 0.76-0.99) and overall use (non-RCTs 7%; 95 CI: 0.86-0.99). Incentives and accountability, communication and patient engagement also showed statistically significant reductions in overall and inappropriate use among RCTs, but were based on fewer studies. CONCLUSIONS: Outpatient physician-targeted behavioural AMS interventions reduce inappropriate antibiotic prescribing and increase recommended/first-line use, with more modest effects on overall volume; intervention effectiveness increased with the number of components.

Abstract as published, via PubMed.

View on PubMedFull text at the publisherOpen in the app

For healthcare professionals. The summary is generated by AI from the published abstract, and the evidence level is assigned automatically from the study design on the Oxford CEBM hierarchy. Neither is medical advice. Read the full paper before changing practice.